Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observational Study of Semaglutide for Obesity and Eating Behavior Patterns
jRCT1041240034Recruiting
- Start
- May 2024
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of semaglutide in obesity, sponsored by none. Primary endpoint: Primary: Difference in BMI changes based on dietary preferences between focus and reference periods. Started May 2024; status: recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on jRCT1041240034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041240034.